Evidence map›Paper›PMID 37913795›Full record

ArticleArchivos de cardiologia de Mexico2023

Chronic hyperkalemia, diagnosis and management. Colombian consensus.

Jorge Rico-Fontalvo, María J Rodríguez-González, Erica Y Yama, Catalina Gallego, Juan Montejo-Hernández, Erika M Martínez, John M Lopera, Luis Echeverria, Rodrigo Daza, José R Pieschacón and 1 more

Open access · diamondAbstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Archivos de cardiologia de Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 4 countries.

Jorge Rico-FontalvoDepartamento de Nefrología, Nephromedicall IPS, Medellín, Antioquia.
María J Rodríguez-GonzálezDepartamento de Cardiología, Unidad de Falla Cardiaca y Trasplante, La Cardio-IC, Bogotá, Cundinamarca.
Erica Y YamaDepartamento de Nefrología, Clínica Colsanitas y Reina Sofía, Bogotá, Cundinamarca.
Catalina GallegoDepartamento de Cardiología, Clínica CardioVID, Medellín, Antioquia.
Juan Montejo-HernándezDepartamento de Nefrología, Nephromedicall IPS, Medellín, Antioquia.
Erika M MartínezDepartamento de Cardiología, Clínica Iberoamericana, Barranquilla, Atlántico.
John M LoperaDepartamento de Nefrología, Hospital Pablo Tobón Uribe, Medellín, Antioquia.
Luis EcheverriaDepartamento de Cardiología, Fundación Cardiovascular de Colombia, Bucaramanga, Santander.
Rodrigo DazaDepartamento de Nefrología, Caminos IPS, Cartagena, Bolívar.
José R PieschacónÁrea de Epidemiología, Evidentias SAS, Bogotá, Cundinamarca.
Efraín A GómezDepartamento de Cardiología, Fundación Clínica Shaio, Bogotá, Cundinamarca. Colombia.
Universidad de Antioquia · CODepartamento de Epidemiología · GTFundación Cardiovascular de Colombia · COFundación Neumológica Colombiana · COHospital Pablo Tobon Uribe · COIbero American University · MXSociedad Española de Cardiología · ESUniversidad Tecnológica de Bolívar · COUniversity of Cundinamarca · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGenerate recommendations for the diagnosis, management, and follow-up of chronic hyperkalemia.

methodThis consensus was made by nephrologists and cardiologists following the GRADE methodology.

resultsChronic hyperkalemia can be defined as a biochemical condition with or without clinical manifestations characterized by a recurrent elevation of serum potassium levels that may require pharmacological and or non-pharmacological intervention. It can be classified as mild (K

conclusionsThe recommendation is to pay attention to the diagnosis, management, and follow-up of chronic hyperkalemia, especially in patients with risk factors.

Indexed as

Heart FailureHyperkalemiaAgedAngiotensin-Converting Enzyme InhibitorsColombiaHumansPotassiumAngiotensin-Converting Enzyme InhibitorsPotassiumAlgorithmsAlgoritmosChelating agentsFactores de riesgoHiperkalemiaHyperkalemiaIncidenceIncidenciaQuelantesRisk factors

Identifiers

PMID37913795
PMCPMC10665005
OpenAlexW4388102732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.